Research.Patient.info
Haematological Malignancy research hub
3 indexed studies · 1 currently recruiting
- recruitingPHASE1, PHASE2
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
This study is testing a new drug, CCS1477 (also called inobrodib), for people with certain blood cancers like lymphoma, myeloma, or leukaemia. It aims to see if the drug is safe, well-tolerated, and how it works in the body.
United States · France · Spain - ongoing, recruitingTherapeutic exploratory (Phase II)
C5691004 _ A dual-cohort, open-label, phase 2 study of brentuximab vedotin and CHP (A+CHP) in the frontline treatment of subjects with peripheral T-cell lymphoma (PTCL) with less than 10% CD30 expression
This study is testing a new way to treat a type of cancer called peripheral T-cell lymphoma (PTCL). Researchers want to see if combining a newer drug (brentuximab vedotin) with standard chemotherapy (CHP) works well for people with a specific type of PTCL.
Spain · Italy · France - ongoing, recruitingPhase I and Phase II (Integrated)- Other
ROMIDEPSIN IN COMBINATION WITH CHOEP AS FIRST LINE TREATMENT BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION IN YOUNG PATIENTS WITH NODAL PERIPHERAL T-CELL LYMPHOMAS: A PHASE I-II STUDY
This study looks at a new drug, Romidepsin, combined with standard treatment (CHOEP) for young people with certain types of lymphoma. It aims to find the safest dose and see how well it works before a stem cell transplant.
Italy